HORSHAM, Pa., Sept. 26, 2018 /PRNewswire-PRWeb/ -- http://Clinicalink.com, the provider of Next-Generation EDC, eCOA
Capture 6 is Clinical Ink's "Next-Generation" EDC and eCOA solution and was purpose-built to capture data during the patient visit allowing true real-time access to both documents and data. In addition to comprehensively updating the entire user experience, innovative new functionality makes data capture, query resolution, and remote monitoring even better for sites and sponsors. Key highlights of Capture 6 include:
"The current EDC market is long overdue for innovation that makes clinical trials easier for sites to conduct and gives sponsors confidence that the data are collected accurately, efficiently, and consistent with the protocol," said Jonathan Andrus, COO Clinical Ink. "We've taken the past 6 years of eSource experience in hundreds of clinical trials and updated our application to simplify even the most complicated tasks so that sites can readily capture data in real-time during the patient visit. Sponsors using Capture 6 will find that sites can readily adopt eSource as part of their routine daily work ensuring cleaner data, faster."
About Clinical Ink Clinical Ink is a global clinical trial technology company that is transforming the clinical trial experience. Founded in 2007, the Company's proven and future-built eSource platform, which includes solutions for Next Generation EDC, eCOA, ePRO and more, accelerates time to value while delivering scientific results that matter. With offices in Winston-Salem, NC, and Philadelphia, PA, Clinical Ink is advancing the business model responsible for bringing new treatments to market. Visit http://www.clinicalink.com
SOURCE Clinical Ink
Subscribe to our Free Newsletters!